Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis

Hereditary amyloidoses are rare and pose a diagnostic challenge. We report a case of hereditary amyloidosis associated with apolipoprotein C-II deposition in a 61-year-old female presenting with renal failure and nephrotic syndrome misdiagnosed as light chain amyloidosis. Renal biopsy was consistent...

Full description

Saved in:
Bibliographic Details
Main Authors: Sadichhya Lohani, Emily Schuiteman, Lohit Garg, Dhiraj Yadav, Sami Zarouk
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Nephrology
Online Access:http://dx.doi.org/10.1155/2016/8690642
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560408449253376
author Sadichhya Lohani
Emily Schuiteman
Lohit Garg
Dhiraj Yadav
Sami Zarouk
author_facet Sadichhya Lohani
Emily Schuiteman
Lohit Garg
Dhiraj Yadav
Sami Zarouk
author_sort Sadichhya Lohani
collection DOAJ
description Hereditary amyloidoses are rare and pose a diagnostic challenge. We report a case of hereditary amyloidosis associated with apolipoprotein C-II deposition in a 61-year-old female presenting with renal failure and nephrotic syndrome misdiagnosed as light chain amyloidosis. Renal biopsy was consistent with amyloidosis on microscopy; however, immunofluorescence was inconclusive for the type of amyloid protein. Monoclonal gammopathy evaluation revealed kappa light chain. Bone marrow biopsy revealed minimal involvement with amyloidosis with kappa monotypic plasma cells on flow cytometry. She was started on chemotherapy for light chain amyloidosis. She was referred to the Mayo clinic where laser microdissection and liquid chromatography mass spectrometry detected high levels of apolipoprotein C-II, making a definitive diagnosis. Apolipoprotein C-II is a component of very low-density lipoprotein and aggregates in lipid-free conditions to form amyloid fibrils. The identification of apolipoprotein C-II as the cause of amyloidosis cannot be solely made with routine microscopy or immunofluorescence. Further evaluation of biopsy specimens with laser microdissection and mass spectrometry and DNA sequencing of exons should be done routinely in patients with amyloidoses for definitive diagnosis. Our case highlights the importance of determining the subtype of amyloidosis that is critical for avoiding unnecessary therapy such as chemotherapy.
format Article
id doaj-art-a3f3ec988fe64a968f3ea8ea062845b4
institution Kabale University
issn 2090-6641
2090-665X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Nephrology
spelling doaj-art-a3f3ec988fe64a968f3ea8ea062845b42025-02-03T01:27:36ZengWileyCase Reports in Nephrology2090-66412090-665X2016-01-01201610.1155/2016/86906428690642Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain AmyloidosisSadichhya Lohani0Emily Schuiteman1Lohit Garg2Dhiraj Yadav3Sami Zarouk4Department of Internal Medicine, Beaumont Health, Royal Oak, MI 48073, USADepartment of Internal Medicine, Beaumont Health, Royal Oak, MI 48073, USALehigh Valley Health Network, Allentown, PA 18103, USAUniversity Hospital Seidman Cancer Center, Case Western University, Cleveland, OH 44106, USADepartment of Nephrology, Beaumont Health, Royal Oak, MI 48073, USAHereditary amyloidoses are rare and pose a diagnostic challenge. We report a case of hereditary amyloidosis associated with apolipoprotein C-II deposition in a 61-year-old female presenting with renal failure and nephrotic syndrome misdiagnosed as light chain amyloidosis. Renal biopsy was consistent with amyloidosis on microscopy; however, immunofluorescence was inconclusive for the type of amyloid protein. Monoclonal gammopathy evaluation revealed kappa light chain. Bone marrow biopsy revealed minimal involvement with amyloidosis with kappa monotypic plasma cells on flow cytometry. She was started on chemotherapy for light chain amyloidosis. She was referred to the Mayo clinic where laser microdissection and liquid chromatography mass spectrometry detected high levels of apolipoprotein C-II, making a definitive diagnosis. Apolipoprotein C-II is a component of very low-density lipoprotein and aggregates in lipid-free conditions to form amyloid fibrils. The identification of apolipoprotein C-II as the cause of amyloidosis cannot be solely made with routine microscopy or immunofluorescence. Further evaluation of biopsy specimens with laser microdissection and mass spectrometry and DNA sequencing of exons should be done routinely in patients with amyloidoses for definitive diagnosis. Our case highlights the importance of determining the subtype of amyloidosis that is critical for avoiding unnecessary therapy such as chemotherapy.http://dx.doi.org/10.1155/2016/8690642
spellingShingle Sadichhya Lohani
Emily Schuiteman
Lohit Garg
Dhiraj Yadav
Sami Zarouk
Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
Case Reports in Nephrology
title Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
title_full Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
title_fullStr Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
title_full_unstemmed Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
title_short Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
title_sort apolipoprotein c ii deposition amyloidosis a potential misdiagnosis as light chain amyloidosis
url http://dx.doi.org/10.1155/2016/8690642
work_keys_str_mv AT sadichhyalohani apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis
AT emilyschuiteman apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis
AT lohitgarg apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis
AT dhirajyadav apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis
AT samizarouk apolipoproteinciidepositionamyloidosisapotentialmisdiagnosisaslightchainamyloidosis